Experimental cell injection targets Hard-to-Treat brain lining tumors
NCT ID NCT06592092
First seen Feb 02, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This early study tested a new treatment called QH104 for people with solid tumors that have spread to the lining of the brain (meningeal metastases). The treatment uses specially engineered immune cells (B7H3 CAR-γδ T cells) injected directly into the fluid around the brain. Only 3 patients took part, and the goal was to see if the treatment is safe and whether it can shrink or control the tumors. Because this is a very small, early-stage study, it is not yet known if this approach will become a standard therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.